Phinomics

Phinomics is a biomarker platform company that focuses on the discovery and exploitation of extrachromosomal circular DNAs (eccDNAs) in precision medicine. Despite their link to various pathologies, such as cancer progression and drug resistance, eccDNAs have remained inaccessible as biomarkers/targets due to technical

Phinomics is a business in health.

Profile

Phinomics is a biomarker platform company that focuses on the discovery and exploitation of extrachromosomal circular DNAs (eccDNAs) in precision medicine. Despite their link to various pathologies, such as cancer progression and drug resistance, eccDNAs have remained inaccessible as biomarkers/targets due to technical and informatic challenges. Phinomics has developed novel technologies, devices, and informatics to […]

The company sits in the health segment, where it competes on its core product or service.

Its current recorded stage is Creative Destruction Lab alumni company.

Website: www.phinomics.com